D75N (p.Asp75Asn) variant of PAH (Phenylalanine-4-hydroxylase)

D75N (p.Asp75Asn) in PAH (Phenylalanine-4-hydroxylase) is a missense change. Clinical records from EBI and UniProt describe it as likely pathogenic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.49 / 1. The record also includes population frequency data, published literature, and structural context.

D75N (p.Asp75Asn) variant details